Aterian (NASDAQ:ATER) Announces Quarterly Earnings Results, Misses Estimates By $0.26 EPS

Aterian (NASDAQ:ATER) announced its quarterly earnings data on Friday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.26), Zacks reports. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.The business had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $20.30 million.

Aterian Stock Performance

NASDAQ ATER opened at $0.50 on Friday. Aterian has a twelve month low of $0.35 and a twelve month high of $1.87. The stock has a market cap of $5.44 million, a PE ratio of -0.25 and a beta of 0.78. The firm has a 50-day simple moving average of $0.97 and a 200 day simple moving average of $0.84.

Institutional Investors Weigh In On Aterian

Several institutional investors have recently modified their holdings of ATER. Citadel Advisors LLC lifted its holdings in Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after buying an additional 22,865 shares during the period. Susquehanna International Group LLP grew its holdings in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after acquiring an additional 30,637 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after acquiring an additional 9,026 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Aterian in the 2nd quarter valued at $55,000. Institutional investors and hedge funds own 7.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on ATER shares. Weiss Ratings raised Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. Wall Street Zen lowered shares of Aterian from a “hold” rating to a “sell” rating in a research note on Saturday, July 25th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Aterian presently has a consensus rating of “Sell”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.